Magnetic nanoparticles for gene and drug delivery
- PMID: 18686777
- PMCID: PMC2527670
- DOI: 10.2147/ijn.s1608
Magnetic nanoparticles for gene and drug delivery
Abstract
Investigations of magnetic micro- and nanoparticles for targeted drug delivery began over 30 years ago. Since that time, major progress has been made in particle design and synthesis techniques, however, very few clinical trials have taken place. Here we review advances in magnetic nanoparticle design, in vitro and animal experiments with magnetic nanoparticle-based drug and gene delivery, and clinical trials of drug targeting.
Figures





References
-
- Abdallah B, Hassan A, Benoist C, et al. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther. 1996;7:1947–54. - PubMed
-
- Akinc A, Thomas M, Klibanov AM, et al. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med. 2005;7:657. - PubMed
-
- Alexiou C, Arnold W, Klein RJ, et al. Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 2000;60:6641–8. - PubMed
-
- Alexiou C, Arnold W, Hulin P, et al. Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting. J Magn Magn Mater. 2001;225:187–93.
-
- Ameur S, Martelet C, Jaffrezic-Renault N, et al. Sensitive immunodetection through impedance measurements onto gold functionalized electrodes. Appl Biochem Biotech. 2000;89:161–70. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources